These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2554603

  • 1. Studies on the development of a medium with peptone and casein hydrolysate for the production of foot-and-mouth disease vaccine in BHK-21 cells.
    Saha SN, Sen AK.
    Vaccine; 1989 Aug; 7(4):357-63. PubMed ID: 2554603
    [Abstract] [Full Text] [Related]

  • 2. Partial replacement of serum with peptone and lactalbumin hydrolysate for the production of foot-and-mouth disease vaccine in BHK-21 cells.
    Saha SN, Sen AK.
    Acta Virol; 1989 Aug; 33(4):338-43. PubMed ID: 2574940
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Laboratory trials of culturing BHK 21 C 13 cells in a roller using an enzymatic egg hydrolysate-based nutrient medium].
    Veleva E, Genov I, Stefanova L, Tekerlekov P, Tivchev G.
    Vet Med Nauki; 1980 Aug; 17(9-10):37-42. PubMed ID: 6266126
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period.
    Radlett PJ, Pay TW, Garland AJ.
    Dev Biol Stand; 1985 Aug; 60():163-70. PubMed ID: 2995169
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Developments in foot-and-mouth disease vaccines.
    Barteling SJ, Vreeswijk J.
    Vaccine; 1991 Feb; 9(2):75-88. PubMed ID: 1647575
    [Abstract] [Full Text] [Related]

  • 10. Development of an inexpensive cell culture medium for the production of foot-and-mouth disease vaccine.
    Chawla SK.
    Arch Gesamte Virusforsch; 1974 Feb; 44(4):401-2. PubMed ID: 4368580
    [No Abstract] [Full Text] [Related]

  • 11. [Developments in foot-and-mouth disease (FMD) vaccine production (author's transl)].
    Barteling SJ.
    Tijdschr Diergeneeskd; 1980 Sep 01; 105(17):695-8. PubMed ID: 6252656
    [Abstract] [Full Text] [Related]

  • 12. Production of a Foot-and-Mouth Disease Vaccine Antigen Using Suspension-Adapted BHK-21 Cells in a Bioreactor.
    Park S, Kim JY, Ryu KH, Kim AY, Kim J, Ko YJ, Lee EG.
    Vaccines (Basel); 2021 May 13; 9(5):. PubMed ID: 34068378
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The use of suspension cultures for FMD vaccine production. Criteria for the evaluation of cells, virus and vaccine.
    Nardelli L, Panina GF.
    Dev Biol Stand; 1976 May 13; 35():9-25. PubMed ID: 198318
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth of the IB-RS-2 pig kidney cell line in suspension culture and its susceptibility to foot-and-mouth disease virus.
    Chapman WG, Ramshaw IA.
    Appl Microbiol; 1971 Jul 13; 22(1):1-5. PubMed ID: 4329431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.